SGLT2 Inhibitors Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

SGLT2 Inhibitors in Treating Patients With PCOS
Condition:   Polycystic Ovary Syndrome Interventions:   Drug: SGLT2 inhibitors combined with metformin;   Drug: Placebo combined with metformin Sponsor:   Shanghai 10th People's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials

SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis
Conditions:   Type 2 Diabetes;   Type 1 Diabetes Interventions:   Drug: Empagliflozin 25 MG;   Other: Placebo Sponsors:   The University of Texas Health Science Center at San Antonio;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials